Nyxoah S.A. (NASDAQ:NYXH) Short Interest Up 164.1% in March

Nyxoah S.A. (NASDAQ:NYXH) was the target of a significant growth in short interest in March. As of March 31st, there was short interest totalling 168,200 shares, a growth of 164.1% from the March 15th total of 63,700 shares. Currently, 1.1% of the shares of the stock are short sold. Based on an average daily volume of 106,100 shares, the short-interest ratio is presently 1.6 days.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in NYXH. LPL Financial LLC acquired a new position in Nyxoah in the fourth quarter valued at approximately $102,000. Walleye Capital LLC boosted its holdings in shares of Nyxoah by 23.9% in the 4th quarter. Walleye Capital LLC now owns 14,831 shares of the company’s stock valued at $119,000 after buying an additional 2,862 shares in the last quarter. Ameriprise Financial Inc. acquired a new stake in Nyxoah during the 4th quarter worth $135,000. Geode Capital Management LLC lifted its position in Nyxoah by 19.4% in the fourth quarter. Geode Capital Management LLC now owns 17,100 shares of the company’s stock valued at $137,000 after acquiring an additional 2,774 shares during the last quarter. Finally, Kovack Advisors Inc. grew its holdings in shares of Nyxoah by 100.0% during the fourth quarter. Kovack Advisors Inc. now owns 20,000 shares of the company’s stock worth $160,000 after purchasing an additional 10,000 shares during the last quarter.

Analyst Ratings Changes

Several research analysts have recently commented on the company. HC Wainwright reiterated a “buy” rating and set a $15.00 price target on shares of Nyxoah in a report on Tuesday, April 8th. Stifel Nicolaus decreased their price objective on Nyxoah from $16.00 to $15.00 and set a “buy” rating on the stock in a report on Friday, March 14th.

Nyxoah Stock Performance

Shares of NYXH remained flat at $5.98 during midday trading on Tuesday. The stock had a trading volume of 76,099 shares, compared to its average volume of 63,420. The company has a current ratio of 5.28, a quick ratio of 4.95 and a debt-to-equity ratio of 0.21. The firm has a market cap of $203.68 million, a price-to-earnings ratio of -3.20 and a beta of 1.55. Nyxoah has a 1-year low of $5.55 and a 1-year high of $12.21. The stock’s 50-day moving average is $9.21 and its two-hundred day moving average is $9.16.

Nyxoah (NASDAQ:NYXH) last posted its quarterly earnings data on Thursday, March 13th. The company reported ($0.49) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.03). Nyxoah had a negative return on equity of 51.68% and a negative net margin of 1,043.93%. The company had revenue of $1.35 million for the quarter, compared to analysts’ expectations of $2.02 million. As a group, equities research analysts forecast that Nyxoah will post -1.91 EPS for the current fiscal year.

About Nyxoah

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.